Ubs Group Ag Johnson & Johnson Call Options Transaction History

Ubs Group Ag

$400 Billion
Q2 2024

Call Options

30 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 13, 2024	BUY	$144.38 - $157.78 $14.2 Million - $15.5 Million	98,100 Added 19.41%	603,495 $88.2 Million
Q1 2024 May 13, 2024	SELL	$155.22 - $162.74 $29.8 Million - $31.2 Million	-191,942 Reduced 27.52%	505,395 $79.9 Million
Q4 2023 Feb 09, 2024	BUY	$145.6 - $158.88 $57.9 Million - $63.2 Million	397,537 Added 132.6%	697,337 $109 Million
Q3 2023 Nov 09, 2023	BUY	$155.75 - $174.48 $7.14 Million - $8 Million	45,870 Added 18.06%	299,800 $46.7 Million
Q2 2023 Aug 11, 2023	BUY	$154.35 - $166.11 $16.5 Million - $17.7 Million	106,600 Added 72.35%	253,930 $42 Million
Q1 2023 May 12, 2023	SELL	$151.05 - $180.26 $12.7 Million - $15.2 Million	-84,070 Reduced 36.33%	147,330 $22.8 Million
Q4 2022 Feb 08, 2023	BUY	$160.2 - $179.79 $11.3 Million - $12.7 Million	70,570 Added 43.88%	231,400 $40.9 Million
Q3 2022 Nov 10, 2022	BUY	$161.33 - $179.52 $11.2 Million - $12.5 Million	69,630 Added 76.35%	160,830 $26.3 Million
Q2 2022 Aug 10, 2022	SELL	$168.19 - $186.01 $7.48 Million - $8.28 Million	-44,500 Reduced 32.79%	91,200 $16.2 Million
Q1 2022 May 16, 2022	SELL	$158.14 - $179.59 $18.4 Million - $20.9 Million	-116,500 Reduced 46.19%	135,700 $24.1 Million
Q4 2021 Feb 14, 2022	BUY	$155.93 - $173.01 $21.2 Million - $23.5 Million	135,979 Added 117.0%	252,200 $43.1 Million
Q3 2021 Nov 15, 2021	SELL	$161.5 - $179.47 $8.11 Million - $9.01 Million	-50,200 Reduced 30.16%	116,221 $18.8 Million
Q2 2021 Aug 13, 2021	SELL	$159.48 - $171.07 $61.4 Million - $65.9 Million	-385,200 Reduced 69.83%	166,421 $27.4 Million
Q1 2021 May 12, 2021	BUY	$153.07 - $170.48 $70.1 Million - $78 Million	457,721 Added 487.46%	551,621 $90.7 Million
Q4 2020 Feb 11, 2021	BUY	$137.11 - $157.38 $233,087 - $267,546	1,700 Added 1.84%	93,900 $14.8 Million
Q3 2020 Nov 12, 2020	BUY	$140.38 - $153.83 $10.8 Million - $11.9 Million	77,200 Added 514.67%	92,200 $13.7 Million
Q2 2020 Jul 31, 2020	SELL	$128.81 - $155.51 $67.9 Million - $82 Million	-527,200 Reduced 97.23%	15,000 $2.11 Million
Q1 2020 May 01, 2020	BUY	$111.14 - $153.99 $53 Million - $73.5 Million	477,000 Added 731.6%	542,200 $71.1 Million
Q4 2019 Feb 14, 2020	BUY	$127.5 - $146.44 $6.92 Million - $7.95 Million	54,300 Added 498.17%	65,200 $9.51 Million
Q3 2019 Nov 14, 2019	SELL	$126.95 - $142.14 $38,085 - $42,641	-300 Reduced 2.68%	10,900 $1.41 Million
Q2 2019 Aug 14, 2019	SELL	$131.15 - $144.24 $13.3 Million - $14.7 Million	-101,600 Reduced 90.07%	11,200 $1.56 Million
Q1 2019 May 14, 2019	BUY	$125.72 - $139.79 $12.6 Million - $14 Million	100,370 Added 807.48%	112,800 $15.8 Million
Q4 2018 Feb 14, 2019	BUY	$122.84 - $147.84 $1.08 Million - $1.3 Million	8,800 Added 242.42%	12,430 $1.6 Million
Q3 2018 Nov 14, 2018	SELL	$121.58 - $142.88 $38.8 Million - $45.6 Million	-319,386 Reduced 98.88%	3,630 $502,000
Q2 2018 Aug 14, 2018	SELL	$119.4 - $131.76 $9.22 Million - $10.2 Million	-77,184 Reduced 19.29%	323,016 $39.2 Million
Q1 2018 May 15, 2018	BUY	$125.1 - $148.14 $39.6 Million - $46.9 Million	316,400 Added 377.57%	400,200 $51.3 Million
Q4 2017 Feb 14, 2018	BUY	$131.22 - $143.62 $4.56 Million - $4.99 Million	34,750 Added 70.85%	83,800 $11.7 Million
Q3 2017 Nov 14, 2017	SELL	$129.47 - $135.38 $33.8 Million - $35.3 Million	-260,950 Reduced 84.18%	49,050 $6.38 Million
Q2 2017 Aug 14, 2017	BUY	N/A	400 Added 0.13%	310,000 $41 Million
Q1 2017 Nov 14, 2017	BUY	N/A	309,600	309,600 $38.6 Million

Others Institutions Holding JNJ

# of Institutions

4,161

Shares Held

1.69B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $434B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account